Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNA Skin Institute is a private skincare and aesthetics company based in Ventura, California that develops and markets science-oriented, organic skincare products for professional and consumer use. The company positions its formulations as non-toxic, certified organic, and built around a proprietary ionic chemistry process intended to improve ingredient compatibility, absorption, and skin support. Its portfolio appears focused on topical skincare products such as cleansers, exfoliants, moisturizers, serums, and professional aesthetic treatments, including its CryoStem-branded offerings. The business is led by founder and CEO Dr. Noel Aguilar and sells through practitioners, spas, and specialty skincare channels rather than operating as a drug-development biotech company. Overall, it is best characterized as a commercial skincare and wellness brand with a biology-inspired formulation story rather than a therapeutic pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DNA Skin Institute.